These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27066551)

  • 1. Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS.
    Tian X; Liang WC; Feng Y; Wang J; Zhang VW; Chou CH; Huang HD; Lam CW; Hsu YY; Lin TS; Chen WT; Wong LJ; Jong YJ
    Neurol Genet; 2015 Aug; 1(2):e14. PubMed ID: 27066551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa.
    Wang J; Zhang VW; Feng Y; Tian X; Li FY; Truong C; Wang G; Chiang PW; Lewis RA; Wong LJ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6213-23. PubMed ID: 25097241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
    Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
    Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.
    Kitamura Y; Kondo E; Urano M; Aoki R; Saito K
    J Hum Genet; 2016 Nov; 61(11):931-942. PubMed ID: 27357428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders.
    Barp A; Mosca L; Sansone VA
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding Neuromuscular Disorders Using Phenotypic Clusters Obtained From Co-Occurrence Networks.
    Díaz-Santiago E; Claros MG; Yahyaoui R; de Diego-Otero Y; Calvo R; Hoenicka J; Palau F; Ranea JAG; Perkins JR
    Front Mol Biosci; 2021; 8():635074. PubMed ID: 34046427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diversity of hereditary neuromuscular diseases: Experiences from molecular diagnosis.
    Hsueh HW; Weng WC; Fan PC; Chien YH; Yang FJ; Lee WT; Lin RJ; Hwu WL; Yang CC; Lee NC
    J Formos Med Assoc; 2022 Dec; 121(12):2574-2583. PubMed ID: 35821219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical exome sequencing in neuromuscular diseases: an experience from Turkey.
    Börklü-Yücel E; Demiriz Ç; Avcı Ş; Vanlı-Yavuz EN; Eraslan S; Oflazer P; Kayserili H
    Neurol Sci; 2020 Aug; 41(8):2157-2164. PubMed ID: 32140910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders.
    Vasli N; Laporte J
    Acta Neuropathol; 2013 Feb; 125(2):173-85. PubMed ID: 23224362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophies and myopathies: the spectrum of mutated genes in the Czech Republic.
    Stehlíková K; Skálová D; Zídková J; Haberlová J; Voháňka S; Mazanec R; Mrázová L; Vondráček P; Ošlejšková H; Zámečník J; Honzík T; Zeman J; Magner M; Šišková D; Langová M; Gregor V; Godava M; Smolka V; Fajkusová L
    Clin Genet; 2017 Mar; 91(3):463-469. PubMed ID: 27447704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
    Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
    Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.
    Bastida JM; Del Rey M; Lozano ML; Sarasquete ME; Benito R; Fontecha ME; Fisac R; García-Frade LJ; Aguilar C; Martínez MP; Pardal E; Aguilera C; Pérez B; Ramos R; Cardesa MR; Martin-Antorán JM; Silvestre LA; Cebeira MJ; Bermejo N; Riesco S; Mendoza MC; García-Sanz R; González-Díaz M; Hernández-Rivas JM; González-Porras JR
    Haemophilia; 2016 Jul; 22(4):590-7. PubMed ID: 26879396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Mutations Associated With Various Types of Corneal Dystrophies in a Han Chinese Population.
    Zhang J; Wu D; Li Y; Fan Y; Chen H; Hong J; Xu J
    Front Genet; 2019; 10():881. PubMed ID: 31555324
    [No Abstract]   [Full Text] [Related]  

  • 14. Next generation sequencing and its application in the diagnostics of neuromuscular diseases.
    Zídková J; Haberlová J; Kramářová T; Fajkusová L
    Cesk Patol; 2021; 57(3):150-153. PubMed ID: 34551563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.
    Cifaldi C; Brigida I; Barzaghi F; Zoccolillo M; Ferradini V; Petricone D; Cicalese MP; Lazarevic D; Cittaro D; Omrani M; Attardi E; Conti F; Scarselli A; Chiriaco M; Di Cesare S; Licciardi F; Davide M; Ferrua F; Canessa C; Pignata C; Giliani S; Ferrari S; Fousteri G; Barera G; Merli P; Palma P; Cesaro S; Gattorno M; Trizzino A; Moschese V; Chini L; Villa A; Azzari C; Finocchi A; Locatelli F; Rossi P; Sangiuolo F; Aiuti A; Cancrini C; Di Matteo G
    Front Immunol; 2019; 10():316. PubMed ID: 31031743
    [No Abstract]   [Full Text] [Related]  

  • 16. Homozygosity mapping guided next generation sequencing to identify the causative genetic variation in inherited retinal degenerative diseases.
    Sundaramurthy S; Swaminathan M; Sen P; Arokiasamy T; Deshpande S; John N; Gadkari RA; Mannan AU; Soumittra N
    J Hum Genet; 2016 Nov; 61(11):951-958. PubMed ID: 27383656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profile and mutation spectrum of Leber congenital amaurosis in a larger Indian cohort using high throughput targeted re-sequencing.
    Srikrupa NN; Srilekha S; Sen P; Arokiasamy T; Meenakshi S; Bhende M; Kapur S; Soumittra N
    Clin Genet; 2018 Feb; 93(2):329-339. PubMed ID: 29068479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axons to Exons: the Molecular Diagnosis of Rare Neurological Diseases by Next-Generation Sequencing.
    Warman Chardon J; Beaulieu C; Hartley T; Boycott KM; Dyment DA
    Curr Neurol Neurosci Rep; 2015 Sep; 15(9):64. PubMed ID: 26289954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing.
    Okazaki T; Murata M; Kai M; Adachi K; Nakagawa N; Kasagi N; Matsumura W; Maegaki Y; Nanba E
    Yonago Acta Med; 2016 Jun; 59(2):118-25. PubMed ID: 27493482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.